Market Research Report
Global Immunosuppressant Drugs Market Forecast 2019-2028
|Published by||Inkwood Research||Product code||939709|
|Published||Content info||135 Pages
Delivery time: 2-3 business days
|Global Immunosuppressant Drugs Market Forecast 2019-2028|
|Published: June 1, 2020||Content info: 135 Pages||
The global immunosuppressant drugs market is projected to register growth at a CAGR of 4.17% during the projected period, 2019-2028. The growing incidences of autoimmune disorders, the growing pharmaceutical industry, and the increase in organ transplantation, are the major factors fueling the market growth.
Organ transplantation has been on the rise across the globe. This is because of the prevalence of genetic conditions like cystic fibrosis, heart defect, and polycystic kidney disease. Infections like hepatitis, damage to organs due to chronic conditions like diabetes, physical injuries, are other factors that are responsible for an organ transplant. Immunosuppressive drugs come into the scene post organ transplantation, while combatting the hyper-immune response of the patient's immune system. Thus, the growing demand for organ transplantation procedures is estimated to have a major impact on the growth of the market. Though immunosuppressive drugs have improved the outcome of organ transplantation, the side effects of such drugs can be serious, and this is one of the major factors hindering the market growth.
The global immunosuppressant drugs market is geographically analyzed through the regions of Europe, North America, Asia Pacific, and the rest of the world. The North America region garnered the largest market share, while the Asia Pacific region is slated to record the highest growth rate by the end of the forecast period. The government funding, prevailing auto-immune diseases, and increasing demands for organ transplantation, contribute to the market prospects of North America.
The competitive environment of the market is evaluated to be stiff, given the workings of the pharmaceutical business. Some of the leading companies in the market are Allergan Plc (Acquired By AbbVie Inc), Bristol-Myers Squibb Company, Cipla Ltd, AbbVie Inc, Astellas Pharma Inc, etc.
Our report offerings include: